Schedule 13G ownership disclosure

Vir Biotechnology Inc

Security class unavailable · CUSIP: 92764N102

Event date: 2019-10-16

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
5,555,556
Percent of class
5.1000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000898432-19-001340
Form type
SC 13G
Filer
Alaska Permanent Fund Corp
CIK
CIK 1582681
Filed
Dec 05, 2019
Reporting period
Oct 16, 2019
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub